| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |